Charles Russell Speechlys double shortlisted for 2017 British Legal Awards
Charles Russell Speechlys has been shortlisted for Private Equity team of the year and Private Client team of the year for the 2017 British Legal Awards. The annual awards celebrate achievement, excellence and innovation in the legal profession.
A notable example of our private equity expertise was our role on the secondary buy-out of Black Rock PM by ICG. David Barry, Principal of BRPM said “The quality of [Charles Russell Speechlys’] advice coupled with the manner in which it was delivered really helped the deal get to the finish line and achieve a successful outcome for all of the management team.” Please click here to read our press release for more information on the deal.
Commenting on the shortlisting, Malcolm MacDougall, partner and head of the private equity team said “we are delighted to be shortlisted for this award. The team showcased excellent project management and teamwork, something that we were able to provide through unique continuity of service dating from the original Dunedin investment, which meant that we had an in depth knowledge of Black Rock’s business.”
Commenting on the shortlisting for Private Client team of the year, Bart Peerless, partner and head of the private client team said:
“We are very pleased to receive this continued recognition. Being shortlisted is a reflection of the team’s achievements both in the UK and internationally. The recent office opening in Hong Kong further extends our ability to support the global private wealth sector and demonstrates our commitment to delivering an outstanding service to our clients.”
The winners will be decided by an independent judging panel at this his year's ceremony, which will take place on Thursday 30 November at Finsbury Square, London EC2.
News & Insights
ECM and Brexit: business as usual?
We consider how ECM could be affected by the UK's impending departure from the EU
Kiadis Pharma secures €20 million debt financing facility from Kreos Capital
Charles Russell Speechlys advises Kreos Capital V Ltd on additional growth capital investment of €20 million in Kiadis Pharma NV